Skip to main content
Deutsch

Detailansicht Person

  1. Medical Neuroscience Cluster
  2. About Us
  3. Members
  4. People
  5. Detailansicht Person
Sorry, this content is only available in German!
Siegfried Kasper
em.o.Univ.Prof.Dr.h.c.mult.Dr.med. Siegfried Kasper

Division of Molecular Neurosciences (Center for Brain Research)
CBR Prof. Emeriti & Guest Profs. (Center for Brain Research)
Position: Prof. emeritus

Location: Spitalgasse 4
Phone: +43 1 40160-34261
E-Mail: siegfried.kasper@meduniwien.ac.at

Further Information

Research Area

Biological Psychiatry, Depression, Genetics, Medical

Research Interests

Neurobiology, Neuropsychopharmacology, Phytotherapy

Principle Investigator(s)

  • Kasper Lab (Head)
  • Kasper, Siegfried (Head)

    • Interest Group(s)

  • Neuropsychopharmacology (Head)
  • Neuroimaging

    • Grant(s)

  • Effects of theta-burst transcranial magnetic stimulation on serotonin-1A receptor binding in treatment resistant depression (Head)
  • Multimodal Assessment of Neurobiological Markers for Psychiatric Disorders (MAN-BIOPSY) (Head)

    • Abstract

    Dr. Siegfried Kasper is Professor of Psychiatry and was Head of the Department of Psychiatry and Psychotherapy at the Medical University of Vienna, Austria. He serves/ed on the executive committees and advisory boards of several national and international societies, such as the European College of Neuropsychopharmacology (ECNP), the European Psychiatric Association (EPA), World Federation of Societies of Biological Psychiatry (WFSBP) and the International College of Neuropsychopharmacology (CINP). Moreover he was Chair of the World Psychiatric Association (WPA) Section of Pharmacopsychiatry. He was Chief-Editor of the World Journal of Biological Psychiatry and the International Journal of Psychiatry in Clinical Practice.

    Selected publications

    1. Kasper S, Iglesias-García C, Schweizer E, Wilson J, DuBrava S, Prieto R, Pitman V, Knapp L (2014) Pregabalin long-term treatment and assessment of discontinuation in patients with generalized anxiety disorder Int J Neuropsychopharmacol, 17 (05): 685-695
    2. Kasper S, Hajak G, Wulff K, Hoogendijk W, Montejo A, Smeraldi E, Rybakowski J, Quera-Salva M, Wirz-Justice A, Picarel-Blanchot F, Baylé F (2010) Efficacy of the Novel Antidepressant Agomelatine on the Circadian Rest-Activity Cycle and Depressive and Anxiety Symptoms in Patients With Major Depressive Disorder J Clin Psychiatry, 71 (02): 109-120
    3. Kasper S, Stein DJ, Loft H, Nil R (2005) Escitalopram in the treatment of social anxiety disorder: Randomised, placebo-controlled, flexible-dosage study Br J Psychiatry, 186 (3): 222-226
    4. Kasper S, Lerman M, McQuade R, Saha A, Carson W, Ali M, Archibald D, Ingenito G, Marcus R, Pigott T (2003) Efficacy and safety of aripiprazole vs. haloperidol for long-term maintenance treatment following acute relapse of schizophrenia Int J Neuropsychopharmacol, 6 (4): 325-337
    5. Kasper S, Wehr TA, Bartko JJ, Gaist PA, Rosenthal NE (1989) Epidemiological Findings of Seasonal Changes in Mood and Behavior Arch Gen Psychiatry, 46 (9): 823

    Show all publications